On Friday, Shares of AT&T Inc. (NYSE:T), gained 0.70% to $32.33.
CSC (CSC) and AT&T (NYSE:T) recently unveiled AT&T NetBond® with CSC Agility PlatformTM to assist manage workloads across hybrid cloud networks.
CSC Agility Platform and AT&T NetBond assist businesses become more flexible and lower costs by moving key apps to the cloud. The joint solution allows the developer to rapidly and consistently provision apps onto cloud and network services using automation. Enterprises can now safely transform to a highly secure hybrid cloud environment.
Moving apps to hybrid clouds can cause enterprise security challenges. The CSC Agility Platform quickly applies policies to all cloud resources. This improves both security and resource administration while reducing audit burdens.
“We’re creating a more consistent blueprint for hybrid cloud apps. This makes the user experience easier and more complete, while improving conformance with enterprise guidelines. The joint solution does just that,” said Dan Hushon, CSC chief technology officer. “This is a step forward for enterprise cloud service — end-to-end control assists the most complex environments work better.”
AT&T Inc. is a holding company. The Company provides telecommunications services. Its services and products comprise wireless communications, data/broadband and Internet services, video services, local exchange services, long-distance services, telecommunications equipment, managed networking and wholesale services.
Shares of JD.Com Inc(ADR) (NASDAQ:JD), inclined 2.37% to $25.94, during its last trading session.
JD.Com declared the launch of Italian Fashion Mall, a new platform on JD.com dedicated to introducing Italian fashion brands and products to consumers in China. JD.com and Europe Design Center also recently jointly declared the participation of three renowned Chinese fashion designers — Lin Gu, Ali Tan and Xiaoyan Xu — in Milan Fashion Week. The three designers were selected through a competitive program run by JD.com and Europe Design Center, and their participation marks the first time Chinese designers will take part in Milan Fashion Week.
The declaration was made at an event during the Milan Fashion Week and was attended by Honorary President of Camera Nazionale della Moda Italiana and Europe Design Center, Mario Boselli; Vice President of JD.com and President of JD Mall’s Apparel and Home Furnishing Business Unit, Lijun Xin; and over 50 guests from the Italian fashion industry.
In addition to bringing top Italian fashion brands to China, JD.com is dedicated to introducing outstanding Chinese fashion talent and brands to the international stage. In August 2015, JD.com and Europe Design Center jointly launched a competitive fashion program to support Chinese designers. Three candidates were selected to take part in Milan Fashion Week through a rigorous process involving assessment by fashion experts in addition to online voting by consumers. Each of the designers’ labels has been recognized as a brand with the potential to succeed internationally.
JD.com, Inc. is an online direct sales company. The Company engages primarily in the sale of electronics and home appliance products and general merchandise products (counting audio, video products and books) sourced from manufacturers, distributors and publishers in People’s republic of China (PRC) on the Internet through its Website jd.com. It also operates its online marketplace under which third-party sellers sell products on the Company’s Website to customers.
Shares of UnitedHealth Group Inc (NYSE:UNH), declined -3.90% to $116.37, during its last trading session.
UnitedHealth Group - Expectant mothers who enroll in UnitedHealthcare Community Plan’s Baby Blocks® interactive incentive program keep healthy-baby appointments and maintain healthy behaviors through their pregnancies, in addition to deliver healthy babies.
Baby Blocks assists new moms manage doctor visits and other baby care during pregnancy and the first 15 months of their baby’s life. The interactive tool is available to women covered by UnitedHealthcare Community Plan in Louisiana and 15 other states. Expectant moms receive incentives for concluding prenatal, postpartum and healthy-baby appointments. Users can access Baby Blocks via a mobile web application on their iPhones and Android smartphones.
“We know there’s a need to assist moms and expectant moms keep up with the number of appointments related to their babies’ health. Baby Blocks is an award-winning resource that can assist fill this need,” said Dr. Ann Kay Logarbo, chief medical officer of UnitedHealthcare Community Plan of Louisiana. “UnitedHealthcare is excited to be able to bring this technology to our customers and see the positive impact it will have on their health and the health of their babies.”
UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms comprise UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace, counting payers, care providers, employers, Governments, life sciences companies and consumers.
Finally, Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF), ended its last trade with -5.38% loss, and closed at $4.75.
Can Fite Biopharma declared that it has reached definitive agreements with institutional investors to receive gross proceeds of $9 million.
In connection with the offering, the Company will issue 2,068,966 registered American Depository Shares (ADSs) of Can-Fite at a purchase price of $4.35 per ADS in a registered direct offering. Additionally, for each ADS purchased by investors, the investors will receive an unregistered warrant to purchase one-half of an ADS. The warrants have an exercise price of $5.25 per ADS, shall be exercisable six months following the issuance date and will expire five and one-half years from the issuance date. The offering is closed on September 23, 2015, subject to the satisfaction of customary closing conditions.
Can Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Company’s drugs are CF101 for Psoriasis treatment, RA treatment, for the treatment of Keratoconjunctictivitis Sicca, for the treatment of Glaucoma, among others; and CF102 for the treatment of liver diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
